EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY-NC 4.0

Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study

Ester P Olthof iD, Hans H B Wenzel iD, Marissa C van Maaren iD, Jacobus van der Velden iD, Anje M Spijkerboer iD, Ruud L M Bekkers iD, Jogchum J Beltman iD, Brigitte F M Slangen iD, Hans W Nijman iD, Ramon G V Smolders iD, Nienke E van Trommel iD, Petra L M Zusterzeel iD und 4 weitere

Journal of Gynecologic Oncology · 2025

DOI: 10.3802/jgo.2025.36.e16 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Ester P Olthof und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Hysterectomy, Lymph Nodes, Chemoradiotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: DCS, KWF Kankerbestrijding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The optimal treatment of clinically early-stage cervical cancer with suspicious lymph nodes on pretreatment imaging is unclear. Therefore, we aimed to compare surgery (i.e., radical hysterectomy and pelvic lymphadenectomy±adjuvant therapy) with primary chemoradiotherapy as treatment strategies in this patient group regarding recurrence-free, overall survival and toxicity. METHODS: Women diagnosed between 2009-2017 with the International Federation of Gynecology and Obstetrics (2009) stage IA-IIA and suspicious nodes based on radiologic assessment of pretreatment imaging were retrospectively selected from the Netherlands Cancer Registry. Cox proportional hazard was used to estimate survival and logistic regression for toxicity. Inverse probability weighting was used to correct for confounding. Grade ≥2 surgery-related (≤30 days) and grade ≥3 chemotherapy or radiotherapy-related (≤6 months) toxicity were collected. Missing data were imputed. RESULTS: Of 330 patients included, 131 (40%) received surgery (followed by adjuvant therapy in 54%) and 199 (60%) chemoradiotherapy. Pathological nodal status was known in 100% of the surgery group and 32% (n=63) of the chemoradiotherapy group, of whom 43% (56/131) and 89% (56/63), respectively, had metastases. After adjustment for confounders, the recurrence-free survival (hazard ratio [HR]=0.67; 95% confidence interval [CI]=0.34-1.31) and overall survival (HR=0.75; 95% CI=0.38-1.47) were not significantly different between both groups, while surgery was associated with more toxicity (odds ratio=2.82; 95% CI=1.42-5.60), mainly surgery-related. CONCLUSION: In patients with clinically early-stage cervical cancer and suspicious nodes on imaging, surgery and primary chemoradiotherapy yielded comparable results in terms of survival, whereas surgery might be associated with more (surgery-related) short-term toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsHysterectomyLymph NodesChemoradiotherapyHumansFemaleRetrospective StudiesMiddle AgedAgedNeoplasm StagingLymph Node ExcisionAdultLymphatic MetastasisChemoradiotherapy, Adjuvant

Stichwörter der Autor:innen

ChemoradiotherapyHysterectomyLymph Node MetastasisSurvivalUterine Cervical Cancer

Autor:innen und Institutionen

  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Department of Gynecological Oncology, Amsterdam University Medical Center, Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam, The Netherlands. e.olthof@iknl.nl.
  • Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
  • Department of Gynecological Oncology, Amsterdam University Medical Center, Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam, The Netherlands.
  • Department of Radiology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
  • Department of Obstetrics and Gynecology, Catharina Hospital, Eindhoven, The Netherlands.

ORCID-Profile: Ester P Olthof, Hans H B Wenzel, Marissa C van Maaren, Jacobus van der Velden, Anje M Spijkerboer, Ruud L M Bekkers, Jogchum J Beltman, Brigitte F M Slangen, Hans W Nijman, Ramon G V Smolders, Nienke E van Trommel, Petra L M Zusterzeel, Ronald P Zweemer, Lukas J A Stalpers, Maaike A van der Aa, Constantijne H Mom

Förderung

  • DCS
  • KWF Kankerbestrijding

Zitieren

APA

Olthof, E. P., Wenzel, H. H. B., van Maaren, M. C., van der Velden, J., Spijkerboer, A. M., Bekkers, R. L. M., Beltman, J. J., Slangen, B. F. M., Nijman, H. W., Smolders, R. G. V., van Trommel, N. E., Zusterzeel, P. L. M., Zweemer, R. P., Stalpers, L. J. A., van der Aa, M. A., & Mom, C. H. (2025). Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e16

Vancouver

Olthof EP, Wenzel HHB, van Maaren MC, van der Velden J, Spijkerboer AM, Bekkers RLM, et al. Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e16

BibTeX
@article{Olthof2025,
  author = {Olthof, Ester P and Wenzel, Hans H B and van Maaren, Marissa C and van der Velden, Jacobus and Spijkerboer, Anje M and Bekkers, Ruud L M and Beltman, Jogchum J and Slangen, Brigitte F M and Nijman, Hans W and Smolders, Ramon G V and van Trommel, Nienke E and Zusterzeel, Petra L M and Zweemer, Ronald P and Stalpers, Lukas J A and van der Aa, Maaike A and Mom, Constantijne H},
  title = {Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study},
  journal = {Journal of Gynecologic Oncology},
  year = {2025},
  doi = {10.3802/jgo.2025.36.e16}
}
Kostenlos starten →